{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-033832","form_type":"8-K","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.699518+00:00","generated_at":"2026-05-15T09:04:44.890307+00:00","sec_items":["5.02","8.01","5.03","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Apimeds US board and CEO ousted; new board approves expansion into Korean cosmetics and photo booth","bullets":["Majority stockholders removed directors Elona Kogan, Jakap Koo, Carol O’Donnell, Dr. Bennett Weintraub via written consent.","CEO Vin Menon and CFO Erick Frim removed; Youngjik Cho appointed CEO, Junyoung Yu as Secretary.","New board approved non-binding MOUs with Assemble, Hilluck (cosmetics distribution) and LK Ventures (Life4Cuts photo booth platform).","Company delays previously announced 1-for-10 reverse stock split; board will continue to evaluate timing.","MindWave issued unauthorized press release challenging the consent; company intends to vigorously defend validity."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-033832","json":"https://secwatch.observer/filing/0001213900-26-033832.json","markdown":"https://secwatch.observer/filing/0001213900-26-033832.md","text":"https://secwatch.observer/filing/0001213900-26-033832.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026033832/0001213900-26-033832-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026033832/ea0283355-8k_apimeds.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:04:44.890307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"df14f225c2dce295a1fd5c62b52c239f05d4d67d","claim":"Apimeds Pharmaceuticals US, Inc.: Amended bylaws to allow majority voting power to fill board vacancies and to confirm amendments may be approved by majority voting power (effective 2026-03-20).","evidence_excerpt":"Pursuant to the Consent, the Majority Stockholders also amended the Amended and Restated Bylaws of the Company, as amended to date, to (a) allow stockholders of the Company holding a majority of the voting power of the Company the power to fill vacancies on the Board and (b) confirm that amendments to the Company’s bylaws may be approved by a majority of the voting power of the Company.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026033832/0001213900-26-033832-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2026-03-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}